Reversal of input tax credit in proportion to exempt supply: specificity of show-cause notice required; order set aside, fresh proceedings allowed wit...
Benami transaction and beneficial ownership: documentary and circumstantial evidence show payors were true beneficiaries, resulting in PBPTA consequen...
Medicines and consumables supplied by a hospital pharmacy to in-patients during diagnosis or treatment are treated as part of a composite supply of healthcare services, not as separate retail sales. The Authority states that in-patient care includes the full bundle of medical, pharmaceutical, paramedical, nursing, laboratory and allied services from admission to discharge, and that such supplies are naturally bundled with the principal healthcare service in the ordinary course of business. Applying section 8(a), the composite supply assumes the character of healthcare services and is exempt under Entry 74 of Notification No. 12/2017-C.T. (Rate); the circular on in-patient healthcare was also relied on as supporting this treatment.
Medicines and consumables supplied by a hospital pharmacy to in-patients during diagnosis or treatment are treated as part of a composite supply of healthcare services, not as separate retail sales. The Authority states that in-patient care includes the full bundle of medical, pharmaceutical, paramedical, nursing, laboratory and allied services from admission to discharge, and that such supplies are naturally bundled with the principal healthcare service in the ordinary course of business. Applying section 8(a), the composite supply assumes the character of healthcare services and is exempt under Entry 74 of Notification No. 12/2017-C.T. (Rate); the circular on in-patient healthcare was also relied on as supporting this treatment.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4817 
Join Channel 
